Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2681 |
|
| Actual shortage: | 255 (10%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2417 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
23 (9%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 3G 0.375G | POWDER FOR SOLUTION | Resolved | 2020-04-10 | 2023-10-04 | 111877 |
| CEFAZOLIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Resolved | 2020-08-20 | 2020-10-08 | 122696 |
| ACT BORTEZOMIB | 3.5MG | POWDER FOR SOLUTION | Resolved | 2020-09-25 | 2020-10-22 | 125031 |
| PEMETREXED DISODIUM FOR INJECTION | 500MG | POWDER FOR SOLUTION | Resolved | 2020-10-30 | 2021-01-07 | 127619 |
| AMPICILLIN SODIUM FOR INJECTION, USP | 500MG | POWDER FOR SOLUTION | Resolved | 2020-11-06 | 2021-03-18 | 128031 |
| CEFTRIAXONE SODIUM FOR INJECTION | 1G | POWDER FOR SOLUTION | Resolved | 2021-01-07 | 2021-02-12 | 131093 |
| TREANDA | 100MG | POWDER FOR SOLUTION | Resolved | 2021-01-28 | 2021-02-11 | 132644 |
| AMPICILLIN SODIUM FOR INJECTION, USP | 1G | POWDER FOR SOLUTION | Resolved | 2021-05-27 | 2021-08-06 | 140036 |
| AMPICILLIN SODIUM FOR INJECTION, USP | 1G | POWDER FOR SOLUTION | Resolved | 2021-06-03 | 2021-08-05 | 140369 |
| AMPICILLIN SODIUM FOR INJECTION, USP | 2G | POWDER FOR SOLUTION | Resolved | 2021-07-08 | 2021-08-24 | 142189 |
| AMPICILLIN SODIUM FOR INJECTION, USP | 500MG | POWDER FOR SOLUTION | Resolved | 2021-08-13 | 2021-10-07 | 144105 |
| CEFAZOLIN FOR INJECTION | 1G | POWDER FOR SOLUTION | Resolved | 2021-08-27 | 2021-10-07 | 144733 |
| CEFOXITIN FOR INJECTION | 2G | POWDER FOR SOLUTION | Resolved | 2021-09-30 | 2021-10-07 | 146440 |
| AMPICILLIN SODIUM FOR INJECTION, USP | 250MG | POWDER FOR SOLUTION | Resolved | 2021-10-28 | 2021-11-25 | 148421 |
| AMPICILLIN SODIUM FOR INJECTION, USP | 1G | POWDER FOR SOLUTION | Resolved | 2022-01-27 | 2022-12-20 | 153739 |
| AMPICILLIN SODIUM FOR INJECTION, USP | 500MG | POWDER FOR SOLUTION | Resolved | 2022-03-31 | 2022-12-20 | 157650 |
| AMPICILLIN SODIUM FOR INJECTION, USP | 500MG | POWDER FOR SOLUTION | Resolved | 2022-04-28 | 2023-01-19 | 159584 |
| TEVA-TOPOTECAN | 4MG | POWDER FOR SOLUTION | Actual shortage | 2022-05-19 | 2022-05-19 | 160980 |
| CEFAZOLIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Resolved | 2022-06-03 | 2022-07-01 | 161934 |
| AMPICILLIN SODIUM FOR INJECTION, USP | 2G | POWDER FOR SOLUTION | Resolved | 2022-06-16 | 2023-04-28 | 162846 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
| ACT OXYCODONE CR | 5MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65328 |
| ACT DONEPEZIL ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64872 |
| ACT DONEPEZIL ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64875 |
| ACT OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2019-10-25 | 2019-10-26 | 97256 |
| ACT OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-01-24 | 2020-01-24 | 104277 |
| TEVA-DEFERASIROX | 500MG | TABLET FOR SUSPENSION | Discontinued | 2019-10-25 | 2019-10-26 | 97248 |
| TEVA-DEFERASIROX | 500MG | TABLET FOR SUSPENSION | Discontinued | 2019-10-31 | 2019-11-01 | 97589 |
| TEVA-DEFERASIROX | 125MG | TABLET FOR SUSPENSION | Discontinued | 2020-01-21 | 2020-01-21 | 103791 |
| TEVA-DEFERASIROX | 250MG | TABLET FOR SUSPENSION | Discontinued | 2020-01-21 | 2020-01-21 | 103796 |